GEZIELTE TRANSFEKTION VON ZELLEN MITTELS BIOTINYLIERTEM DENDRIMER
    5.
    发明授权
    GEZIELTE TRANSFEKTION VON ZELLEN MITTELS BIOTINYLIERTEM DENDRIMER 有权
    生物素化的树枝状细胞有针对性的转染

    公开(公告)号:EP1274462B1

    公开(公告)日:2008-11-19

    申请号:EP01936172.4

    申请日:2001-04-03

    申请人: QIAGEN GmbH

    IPC分类号: A61K47/48 C12N15/87

    摘要: The invention relates to a method for carrying out the targeted transfection of cells, to compositions, which can be used for such methods, and to corresponding medicaments for use in gene therapy. The invention particularly relates to a method for introducing nucleic acid into cells involving the following steps: (a) mixing a nucleic acid with a dendrimer, whereby a portion of the dendrimer molecules is biotinylated; mixing the prepared complex, which consists of a nucleic acid and a dendrimer, with a second complex, which consists of an avidin or a streptavidin and of a biotinylated target-specific binding molecule, and; (c) incubating the complex prepared in step (b) with cells. Dendrimers that are well-suited for the invention are, for example, partially solvolyzed polyamidoamine (PAMAM) dendrimers. Target-specific binding molecules are, in particular, cell type-specific markers also of the cell surface of the target cells.

    GEZIELTE TRANSFEKTION VON ZELLEN MITTELS BIOTINYLIERTEM DENDRIMER
    6.
    发明公开
    GEZIELTE TRANSFEKTION VON ZELLEN MITTELS BIOTINYLIERTEM DENDRIMER 有权
    生物素化的树枝状细胞有针对性的转染

    公开(公告)号:EP1274462A2

    公开(公告)日:2003-01-15

    申请号:EP01936172.4

    申请日:2001-04-03

    申请人: QIAGEN GmbH

    IPC分类号: A61K47/48 C12N15/87

    摘要: The invention relates to a method for carrying out the targeted transfection of cells, to compositions, which can be used for such methods, and to corresponding medicaments for use in gene therapy. The invention particularly relates to a method for introducing nucleic acid into cells involving the following steps: (a) mixing a nucleic acid with a dendrimer, whereby a portion of the dendrimer molecules is biotinylated; mixing the prepared complex, which consists of a nucleic acid and a dendrimer, with a second complex, which consists of an avidin or a streptavidin and of a biotinylated target-specific binding molecule, and; (c) incubating the complex prepared in step (b) with cells. Dendrimers that are well-suited for the invention are, for example, partially solvolyzed polyamidoamine (PAMAM) dendrimers. Target-specific binding molecules are, in particular, cell type-specific markers also of the cell surface of the target cells.